The genesis of RNA interference, its potential clinical applications, and implications in gynecologic cancer

Gynecologic Oncology

Volumn 99, Issue 3, 2005, Pages 736-741

  Tebes, Stephen J ^a,c   Kruk, Patricia A ^b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Gynecologic cancer; Ovarian cancer; RNA interference; Small interfering RNA

Indexed keywords

ADENOVIRUS VECTOR; DNA; LENTIVIRUS VECTOR; MESSENGER RNA; MICRORNA; OLIGONUCLEOTIDE; PLASMID VECTOR; RETROVIRUS VECTOR; RNA INDUCED SILENCING COMPLEX; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

CANCER; CANCER CELL; CANCER THERAPY; DEGENERATIVE DISEASE; DRUG DESIGN; ENDOMETRIUM CANCER; FIBROSARCOMA; FUNCTIONAL GENOMICS; GENE DELIVERY SYSTEM; GENE GUN; GENE SILENCING; GENE TARGETING; GYNECOLOGIC CANCER; HEPATITIS C VIRUS; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW; RNA CLEAVAGE; RNA INTERFERENCE; RNA PURIFICATION; RNA SEQUENCE; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION;

ANIMALS; FEMALE; GENE THERAPY; GENITAL NEOPLASMS, FEMALE; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 28044451281     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.031     Document Type: Review

References (61)

1. C. Cogoni, and G. Macino Post-transcriptional gene silencing across kingdoms Curr. Opin. Genet. Dev. 10 2000 638 643
2. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
3. P. Gonczy, C. Echeverri, K. Oegema, A. Coulson, S.J. Jones, and R.R. Copley Functional genomic analysis of cell division in C. elegans using RNAi of genes on Chromosome III Nature 408 2000 331 336
4. A.G. Fraser, R.S. Kamath, P. Zipperlen, M. Martinez-Campos, M. Sohrmann, and J. Ahringer Functional genomic analysis of C. elegans chromosome I by systematic RNA interference Nature 408 2000 325 330
5. R.S. Kamath, A.G. Fraser, Y. Dong, G. Poulin, R. Durbin, and M. Gotta Systematic functional analysis of the Caenorhabditis elegans genome using RNAi Nature 421 2003 231 237
6. S.M. Hammond, E. Bernstein, D. Beach, and G.J. Hannon An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells Nature 404 2000 293 295
7. B.R. Cullen Derivation and function of small interfering RNAs and micro RNAs Virus Res. 102 2004 3 9
8. E. Bernstein, A.A. Caudy, S.M. Hammond, and G.J. Hannon Role for bidentate ribonuclease in the initiation step of RNA interference Nature 409 2001 363 366
9. A.J. Hamilton, and D.C. Baulcombe A species of small antisense RNA in posttranscriptional gene silencing in plants Science 286 1999 950 952
10. L. Manche, S.R. Green, C. Schmedt, and M.B. Mathews Interactions between double-stranded RNA regulators and the protein kinase DAI Mol. Cell. Biol. 12 1992 5238 5248
11. S.M. Hammond, S. Boettcher, A.A. Caudy, R. Kobayashi, and G.J. Hannon Argonaute 2, a link between genetic and biochemical analyses of RNAi Science 293 2001 1146 1150
12. F.V. Rivas, N.H. Tolia, J.J. Song, J.P. Aragon, J. Liu, and G.J. Hannon Purified Argonaute2 and an siRNA form recombinant human RISC Nat. Struct. Mol. Biol. 12 2005 340 349
13. Hutvágner G, Zamore PD, A microRNA in a multiple-turnover RNAi enzyme complex. Science 200;297:2056-60.
14. C.D. Novina, and P.A. Sharp The RNAi revolution Nature 430 2004 161 164
15. M. Lagos-Quintana, R. Rauhut, W. Lendeckel, and T. Tuschl Identification of novel genes coding for small expressed RNAs Science 294 2001 853 858
16. N.C. Lau, L.P. Lim, E.G. Weinstein, and D.P. Bartel An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans Science 294 2001 858 862
17. R.C. Lee, and V. Ambros An extensive class of small RNAs in Caenorhabditis elegans Science 294 2001 862 864
18. Y. Lee, K. Jeon, J.T. Lee, S. Kim, and V.N. Kim MicroRNA maturation: stepwise processing and subcellular localization EMBO J. 21 2001 4663 4670
19. L.P. Lim, M.E. Glasner, S. Yekta, C.B. Gurge, and D.P. Bartel Vertebrate microRNA genes Science 299 2003 1540
20. O. Voinnet RNA silencing as a plant immune system against viruses Trends Genet. 17 2001 449 459
21. B.J. Reinhart, F.J. Slack, M. Basson, A.E. Pasquinelli, J.C. Bettinger, and A.E. Rougvie The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans Nature 403 2000 901 906
22. P. Xu, S.Y. Vernooy, M. Guo, and B.A. Hay The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism Curr. Biol. 13 2003 790 795
23. S. Griffiths-Jones The microRNA registry Nucleic Acids Res. 32 2004 D109 D111
24. T.C. Karagiannis, and A. El-Osta Mechanism of RNA interference, in vivo and potential clinical applications Cancer Biol. Ther. 3 2004 e116 e121
25. C.D. Novina, and P.A. Sharp The RNAi revolution Nature 430 2004 161 164
26. J.G. Doench, C.P. Petersen, and P.A. Sharp siRNAs can function as miRNAs Genes Dev. 17 2003 438 442
27. Y. Zeng, R. Yi, and B.R. Cullen MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms Proc. Natl. Acad. Sci. U. S. A. 100 2003 5779 5784
28. M.T. Lotze, and T.A. Kost Viruses as gene delivery vectors: application to gene function, target validation, and assay development Cancer Gene Ther. 9 2002 692 699
29. X.F. Qin, D.S. An, I.S. Chen, and D. Baltimore Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 Proc. Natl. Acad. Sci. U. S. A. 100 2003 183 188
30. T. Abbas-Terki, W. Blanco-Bose, N. Deglon, W. Pralong, and P. Aebischer Lentiviral-mediated RNA interference Hum. Gene Ther. 13 2002 2197 2201
31. G.M. Barton, and R. Medzhitov Retroviral delivery of small interfering RNA into primary cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 14943 14945
32. E. Devroe, and P.A. Silver Retrovirus-delivered siRNA BMC Biotechnol. 2 2002 15
33. C. Shen, A.K. Buck, X. Liu, M. Winkler, and S.N. Reske Gene silencing by adenovirus-delivered siRNA FEBS Lett. 539 2003 111 114
34. S.A. Audouy, L.F. de Leij, D. Hoekstra, and G. Molema In vivo characteristics of cationic liposomes as delivery vectors for gene therapy Pharm. Res. 19 2002 1599 1605
35. T. Merdan, J. Kopecek, and T. Kissel Prospects for cationic polymers in gene and oligonucleotide therapy against cancer Adv. Drug Deliv. Rev. 54 2002 715 758
36. T. Niidome, and L. Huang Gene therapy progress and prospects: nonviral vectors Gene Ther. 9 2002 1647 1652
37. R.M. Schiffelers, M.C. Woodle, and P. Scaria Pharmaceutical prospects for RNA interference Pharm. Res. 21 2004 1 7
38. J. Downward RNA interference Br. Med. J. 328 2004 1245 1248
39. D.L. Lewis, J.E. Hagstrom, A.G. Loomis, J.A. Wolff, and H. Herweijer Efficient delivery of siRNA for inhibition of gene expression in postnatal mice Nat. Genet. 32 2002 107 108
40. A.P. McCaffrey, L. Meuse, T.T. Pham, D.S. Conklin, G.J. Hannon, and M.A. Kay RNA interference in adult mice Nature 418 2002 38 39
41. E. Song, S.K. Lee, J. Wang, N. Ince, N. Ouyang, and J. Min RNA interference targeting Fas protects mice from fulminant hepatitis Nat. Med. 9 2003 347 351
42. C. Klein, C.T. Bock, H. Wedemeyer, T. Wustefeld, S. Locarnini, and H.P. Dienes Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA Gastroenterology 125 2003 9 18
43. A.P. McCaffrey, H. Nakai, K. Pandey, Z. Huang, F.H. Salazar, and H. Xu Inhibition of hepatitis B virus in mice by RNA interference Nat. Biotechnol. 21 2003 639 644
44. H. Xia, Q. Mao, H.L. Paulson, and B.L. Davidson siRNA-mediated gene silencing in vitro and in vivo Nat. Biotechnol. 20 2002 1006 1010
45. S.J. Reich, J. Fosnot, A. Kuroki, W. Tang, X. Yang, and A.M. Maguire Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model Mol. Vision 9 2003 210 216
46. S. Filleur, A. Courtin, S. Ait-Si-Ali, J. Guglielmi, C. Merle, and A. Harel-Bellan SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth Cancer Res. 63 2003 3919 3922
47. G. Yang, K.Q. Cai, J.A. Thompson-Lanza, R.C. Bast Jr., and J. Liu Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression J. Biol. Chem. 279 2004 4339 4345
48. G. Yang, J.A. Thompson, B. Fang, and J. Liu Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumor growth in a model of human ovarian cancer Oncogene 22 2003 5694 5701
49. A. Choudhury, J. Charo, S.K. Parapuram, R.C. Hunt, D.M. Hunt, and B. Seliger Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, up-regulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines Int. J. Cancer 108 2004 71 77
50. J.A. Menendez, L. Vellon, I. Mehmi, B.P. Oza, S. Ropero, and R. Colomer Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells Proc. Natl. Acad. Sci. U. S. A. 101 2004 10715 10720
51. S. Miyamoto, M. Hirata, A. Yamazaki, T. Kageyama, H. Hasuwa, and H. Mizushima Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy Cancer Res. 64 2004 5720 5727
52. Z. Duan, K.A. Brakora, and M.V. Seiden Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells Mol. Cancer Ther. 3 2004 833 838
53. T. Zhang, M. Guan, H. Jin, and Y. Lu Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells Gynecol. Oncol. 97 2005 501 507
54. M. Jiang, and J. Milner Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs Methods Mol. Biol. 292 2005 401 420
55. M. Yoshinouchi, T. Yamada, M. Kizaki, J. Fen, T. Koseki, and Y. Ikeda In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA Mol. Ther. 8 2003 762 768
56. V. Gagnon, I. Mathieu, E. Sexton, K. Leblanc, and E. Asselin AKT involvement in cisplatin chemoresistance of human uterine cancer cells Gynecol. Oncol. 94 2004 785 795
57. W. Chien, T. Kumagai, C.W. Miller, J.C. Desmond, J.M. Frank, and J.W. Said Cyr61 suppresses growth of human endometrial cancer cells J. Biol. Chem. 279 2004 53087 53096
58. R.C.C. Ryther, A.S. Flynt, J.A. Phillips, and J.G. Patton siRNA therapeutics: big potential from small RNAs Gene Ther. 12 2005 5 11
59. F. Czauderna, M. Fechtner, S. Dames, H. Aygun, A. Klippel, and G.J. Pronk Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells Nucleic Acid Res. 31 2003 2705 2716
60. Y.L. Chiu, and T. Rana siRNA function in RNAi: a chemical modification analysis RNA 9 2003 1034 1048
61. M. Amarzguioui, T. Holen, E. Babaie, and H. Prydz Tolerance for mutations and chemical modifications in a siRNA Nucleic Acids Res. 31 2003 589 595